Home > Healthcare > Medical Devices > Diagnostic Devices > Blood Transfusion Diagnostics Market

Blood Transfusion Diagnostics Market Trends

Report ID: GMI5607
Published Date: May 2023
Report Format: PDF

Download Free Sample

Blood Transfusion Diagnostics Market Trends

Increasing prevalence of chronic diseases and blood related disorders is proving beneficial for the market growth. Significant upsurge in blood related disorders has augmented the demand for blood transfusion among patients in several healthcare facilities. Some of the major disorders including thrombocytopenia, hemophilia, and leukocytosis among others require blood transfusion for the diagnosis and treatment.

Additionally, availability of advanced blood screening devices offers safe and effective blood transfusion for the recipients. The incidence of blood diseases is further forecasted to increase substantially in the elderly population aged 65 years or above. The rise in blood diseases and related mortality offers immense potential for business growth and opportunity for the market players to establish and penetrate the untapped market. Thus, the growing prevalence of chronic and blood-related disorders is expected to expedite the blood transfusion diagnostics industry statistics.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Blood transfusion diagnostics industry size was USD 4.6 billion in 2022 and will reach USD 8.8 billion by 2032 due to the growing burden of chronic diseases and blood related disorders.

Blood transfusion diagnostics market share from reagents & kits reached USD 3 billion in 2022 owing to the incessant need for precise and accurate screening as well as management of blood transfusion diagnostics.

Demand for blood transfusion diagnostics in the U.S. recorded USD 1.8 billion in 2022 and will significantly grow through 2023-2032 on account of the surging healthcare expenditure in the region.

Abbott Laboratories, BAG Healthcare GmBH, Bio-Rad Laboratories, Inc, Diagnostica Stago, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd, Grifols S.A., Merck KGaA, Ortho Clinical Diagnostics, Quotient Ltd and Thermo Fisher Scientific Inc. are some well-known blood transfusion diagnostic industry players.